645 related articles for article (PubMed ID: 29544865)
61. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
[TBL] [Abstract][Full Text] [Related]
62. Long-term prognosis after primary PCI in unselected patients with ST-elevation myocardial infarction.
Barchielli A; Santoro GM; Balzi D; Carrabba N; Di Bari M; Gensini GF; Filice M; Landini CM; Valente S; Zuppiroli A; Marchionni N
J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):819-27. PubMed ID: 22772599
[TBL] [Abstract][Full Text] [Related]
63. Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction - Relationship With Infarct Size, Adverse Remodeling, and Events at 1 Year.
Cuenin L; Lamoureux S; Schaaf M; Bochaton T; Monassier JP; Claeys MJ; Rioufol G; Finet G; Garcia-Dorado D; Angoulvant D; Elbaz M; Delarche N; Coste P; Metge M; Perret T; Motreff P; Bonnefoy-Cudraz E; Vanzetto G; Morel O; Boussaha I; Ovize M; Mewton N
Circ J; 2018 Apr; 82(5):1379-1386. PubMed ID: 28943533
[TBL] [Abstract][Full Text] [Related]
64. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
65. Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.
Fu WX; Zhou TN; Wang XZ; Zhang L; Jing QM; Han YL
Chin Med J (Engl); 2018 Jun; 131(12):1420-1429. PubMed ID: 29893358
[TBL] [Abstract][Full Text] [Related]
66. A simple angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.
Chen G; Westra J; Yang X; Zhang Y; Luo D; Hu X; Li G; Zhou Y; Tu S; Dong H
Int J Cardiol; 2024 Aug; 409():132199. PubMed ID: 38782068
[TBL] [Abstract][Full Text] [Related]
67. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry.
Manari A; Varani E; Guastaroba P; Menozzi M; Valgimigli M; Menozzi A; Magnavacchi P; Franco N; Marzocchi A; Casella G
Catheter Cardiovasc Interv; 2014 Nov; 84(6):912-22. PubMed ID: 24403174
[TBL] [Abstract][Full Text] [Related]
68. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
[TBL] [Abstract][Full Text] [Related]
69. Prognostic importance of mitral regurgitation complicated by acute myocardial infarction during a 5-year follow-up period in the drug-eluting stent era.
Kim TH; Lee KY; Choi Y; Park HW; Lee YS; Koh YS; Park HJ; Kim PJ; Chang K; Chung WS; Kim DB; Her SH; Park CS; Lee JM; Kim HY; Yoo KD; Jeon DS; Ahn Y; Jeong MH; Seung KB
Coron Artery Dis; 2016 Mar; 27(2):109-15. PubMed ID: 26626143
[TBL] [Abstract][Full Text] [Related]
70. Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the "Codi IAM" Multicenter Registry).
García-García C; Oliveras T; Rueda F; Pérez-Fernández S; Ferrer M; Serra J; Labata C; Vila J; Carrillo X; Rodríguez-Leor O; Fernández-Nofrerias E; Faixedas MT; Jiménez J; Mauri J; Lupón J; Bayes-Genis A
Am J Cardiol; 2018 Aug; 122(4):529-536. PubMed ID: 29960663
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of stent length on the outcome of ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.
Fukutomi M; Takahashi M; Toriumi S; Ogoyama Y; Oba Y; Funayama H; Kario K
Coron Artery Dis; 2019 May; 30(3):196-203. PubMed ID: 30973831
[TBL] [Abstract][Full Text] [Related]
72. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
[TBL] [Abstract][Full Text] [Related]
73. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
[TBL] [Abstract][Full Text] [Related]
74. Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.
Nijhoff F; Agostoni P; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Stella PR
Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S34-44. PubMed ID: 26119971
[TBL] [Abstract][Full Text] [Related]
75. Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study.
Nochioka K; Biering-Sørensen T; Hansen KW; Sørensen R; Pedersen S; Jørgensen PG; Iversen A; Shimokawa H; Jeger R; Kaiser C; Pfisterer M; Galatius S;
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):778-786. PubMed ID: 27166320
[TBL] [Abstract][Full Text] [Related]
76. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
[TBL] [Abstract][Full Text] [Related]
77. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
78. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
79. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
Ertelt K; Brener SJ; Mehran R; Ben-Yehuda O; McAndrew T; Stone GW
Am J Cardiol; 2017 Jun; 119(12):1917-1923. PubMed ID: 28427734
[TBL] [Abstract][Full Text] [Related]
80. Tpeak-Tend/QT interval predicts ST-segment resolution and major adverse cardiac events in acute ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Wang X; Zhang L; Gao C; Zhu J; Yang X
Medicine (Baltimore); 2018 Oct; 97(43):e12943. PubMed ID: 30412109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
